IDEXX Laboratories, Inc. (IDXX) is a Medical diagnostics research company in the Healthcare sector, listed on Nasdaq. This page provides the complete earnings calendar, dividend schedule, and financial data for IDEXX Laboratories, Inc. in 2026. The next earnings report is expected on November 3, 2026.
Next earnings date
03 Nov 2026
In 75 days
EPS estimate
3.77
Revenue estimate
1.2B
Past earnings
Latest earnings analysis
IDEXX Laboratories, Inc. beat consensus estimates in its latest earnings report, with EPS of $4.27 coming in 8.3% above expectations and revenue of $1.22 billion exceeding estimates by 1.4%. Both EPS and revenue also came in ahead of expectations in the previous report.
No dividend history available.
IDEXX Laboratories, Inc. is a global enterprise dedicated to creating, producing, and distributing a broad spectrum of products and services. Its primary focus lies in serving the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company delivers crucial solutions across several key areas. For companion animals, IDEXX offers comprehensive veterinary diagnostic tools, including in-clinic point-of-care instruments, consumables, and rapid assay test kits. They also provide expert veterinary reference laboratory diagnostics, consulting services, and advanced practice management and diagnostic imaging systems. Beyond pets, their portfolio extends to health monitoring and diagnostic products vital for livestock, poultry, and dairy farming. In the water quality segment, IDEXX manufactures tests designed to detect various microbiological contaminants, ensuring safety and compliance, with notable examples like the Colilert, Enterolert, and Legiolert tests. IDEXX also serves the biomedical research community with health monitoring and laboratory animal diagnostic instruments and services. Furthermore, they contribute to human point-of-care medical diagnostics by providing specialized electrolytes and blood gas analyzers, alongside SARS-CoV-2 RT-PCR solutions. Their extensive product lineup features various in-clinic chemistry, blood, and urine analyzers (such as the SediVue Dx), hematology systems, and rapid diagnostic assays like SNAP test kits. Complementing these offerings, the company provides essential veterinary software solutions for both independent and corporate veterinary practices. Sales and distribution are managed through their dedicated marketing, customer service, sales, and technical support teams, supplemented by a network of independent distributors and other resellers. Established in 1983, IDEXX Laboratories, Inc. maintains its headquarters in Westbrook, Maine.
IDEXX Laboratories, Inc. (IDXX) is scheduled to report earnings on November 3, 2026.
IDEXX Laboratories, Inc. (IDXX) last reported earnings on August 4, 2026.
IDEXX Laboratories, Inc. (IDXX) is listed on Nasdaq.
We use cookies to make our website work and improve your experience. With your consent, we also use cookies for analytics and advertising.